Get started
Author

Hanae Morio

Observed names: HANAE MORIO, MORIO, Hanae, Morio, Hanae, 森尾, 花恵
ORCID: 0000-0002-1276-1283
Observed ORCID: 0000-0002-1276-1283
OpenAlex ID: A5066525259
JPH203, a newly developed anti-cancer drug, shows a preincubation inhibitory effect on L-type amino acid transporter 1 function
2020 · Kentaro Okunushi, Tomomi Furihata, et al. · Journal of Pharmacological Sciences · 42
PDF
Different Response Profiles of Gastrointestinal Cancer Cells to an L-Type Amino Acid Transporter Inhibitor, JPH203
2018 · YASUHIDE MUTO, TOMOMI FURIHATA, et al. · Anticancer Research · 42
PDF
Development, Characterization and Potential Applications of a Multicellular Spheroidal Human Blood–Brain Barrier Model Integrating Three Conditionally Immortalized Cell Lines
2021 · Keita Kitamura, Kenta Umehara, et al. · Biological and Pharmaceutical Bulletin · 25
PDF
Cancer-Type OATP1B3 mRNA in Extracellular Vesicles as a Promising Candidate for a Serum-Based Colorectal Cancer Biomarker
2018 · Hanae Morio, Yuchen Sun, et al. · Biological and Pharmaceutical Bulletin · 18
PDF
Human organic anion transporter 2 is an entecavir, but not tenofovir, transporter
2016 · Tomomi Furihata, Hanae Morio, et al. · Drug Metabolism and Pharmacokinetics · 16
Human Immortalized Cell-Based Blood–Brain Barrier Spheroid Models Offer an Evaluation Tool for the Brain Penetration Properties of Macromolecules
2022 · Keita Kitamura, Ayaka Okamoto, et al. · Molecular Pharmaceutics · 15
Synthesis of novel benzbromarone derivatives designed to avoid metabolic activation
2018 · Tomoyuki Ohe, Ryutaro Umezawa, et al. · Bioorganic & Medicinal Chemistry Letters · 14
Differentiated HASTR/ci35 cells: A promising in vitro human astrocyte model for facilitating CNS drug development studies
2018 · Keita Kitamura, Ryo Ito, et al. · Journal of Pharmacological Sciences · 14
PDF
Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans -splicing technology
2018 · Yuchen Sun, Josefina Piñón Hofbauer, et al. · Cancer Letters · 13
In Vitro-In Vivo Correlation of Blood–Brain Barrier Permeability of Drugs: A Feasibility Study Towards Development of Prediction Methods for Brain Drug Concentration in Humans
2022 · Ryo Ito, Hanae Morio, et al. · Pharmaceutical Research · 11
Generation of a Human Conditionally Immortalized Cell-based Multicellular Spheroidal Blood-Brain Barrier Model for Permeability Evaluation of Macromolecules
2022 · Ryuto Isogai, Hanae Morio, et al. · BIO-PROTOCOL · 9
Differential inhibition features of direct-acting anti-hepatitis C virus agents against human organic anion transporting polypeptide 2B1
2015 · Tomomi Furihata, Zhongguo Fu, et al. · International Journal of Antimicrobial Agents · 9
Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer
2022 · Katharina Woess, Yuchen Sun, et al. · International Journal of Molecular Sciences · 7
PDF
Development of a New Conditionally Immortalized Human Liver Sinusoidal Endothelial Cells
2018 · Meiyan Zhu, Akira Koibuchi, et al. · Biological and Pharmaceutical Bulletin · 6
PDF
Protein kinase C activation upregulates human L-type amino acid transporter 2 function
2021 · Hanae Morio, Yoshie Reien, et al. · The Journal of Physiological Sciences · 5
PDF
Transferrin receptor-targeting property of pabinafusp alfa facilitates its uptake by various types of human brain-derived cells in vitro
2023 · Tomoki Fukatsu, Hanae Morio, et al. · Frontiers in Drug Delivery · 4
Effects of islatravir (4′-ethynyl-2-fluoro-2′-deoxyadenosine or EFdA) on renal tubular cells and islatravir's interactions with organic anion transporters
2021 · Meika Kaneko, Yoshie Reien, et al. · Journal of Pharmacological Sciences · 4
PDF
Translational applicability of human blood-brain barrier spheroid models for the development of brain-penetrant therapeutic antibodies
2026 · Seiya Ohki, Tomoki Fukatsu, et al. · Fluids and Barriers of the CNS · 1
Functional assessment of immortalized human brain microvascular endothelial cells with different passage numbers: A case study for a prospective proposal on variability management of in vitro blood-brain barrier models
2025 · Seiya Ohki, Mei Fukuda, et al. · Drug Metabolism and Pharmacokinetics · 1
Human blood–brain barrier spheroid models for the evaluation of drugs targeting brain vascular inflammation
2026 · Ayuka Ebisawa, Hanae Morio, et al. · Journal of Pharmacological Sciences
Translational applicability of human blood-brain barrier spheroid models for the development of brain-penetrant therapeutic antibodies
2026 · Ohki, Seiya, Fukatsu, Tomoki, et al. · Figshare
Additional file 1 of Translational applicability of human blood-brain barrier spheroid models for the development of brain-penetrant therapeutic antibodies
2026 · Ohki, Seiya, Fukatsu, Tomoki, et al. · Figshare
Characterization of human immortalized cell-based blood-brain barrier spheroid models as a tool for brain vascular inflammation studies
2025 · Hanae Morio, Ayuka Ebisawa, et al. · Drug Metabolism and Pharmacokinetics
Multicellular spheroidal human blood-brain barrier models are a useful tool for characterization of brain-penetrating antibodies
2025 · Seiya Ohki, Kana Yamamoto, et al. · Drug Metabolism and Pharmacokinetics
[千葉医学会奨励賞] プロテインキナーゼcの活性化はヒトl型アミノ酸トランスポーター2の機能を向上させる
2022 · 森尾, 花恵 · Institutional Repositories DataBase (IRDB)
PDF
Works count: 34
Citation count: 255
H-index: 10
I10-index: 10
Year
Topic
Type